Geranylgeraniol, a polyprenylalcohol composing the side chain inducing activity against freshly isolated leukemia cells in of vitamin K2 (VK2), was previously reported to be a potent vitro. Kirin Brewery (Maebashi, Gunma, Japan). data suggest the possibility of using VK2 and its derivatives for the treatment of myelogenous leukemias, including APL.
Introduction
MDS92, an IL-3-dependent myeloid cell line, was established from a patient with MDS (RA with ringed sideroblasts), 6 and Vitamin K (VK) is a generic term for compounds that include was cultured in RPMI 1640 medium supplemented with 10% phytonadione (VK1), the menaquinone series (VK2), and men-FBS and 200 U/ml of recombinant human IL-3. adione (VK3). Physiologically, the natural K vitamins, VK1 and Leukemia cells were freshly isolated from bone marrow or VK2, are known to act as cofactors for ␥-carboxylation of peripheral blood samples obtained from 12 patients with leuselected glutamates at the N-termini of prothrombin and other kemia after informed consent. The diagnosis of AML and MDS VK-dependent coagulation factors. The congeners of VK share was based on the criteria of the French-Americana common chemical structure consisting of a naphthoquinone British (FAB) classification. The patients included four with nucleus capable of redox cycling. VK1 has a long phytol side AML (two M2 and two M3), two with CML in blastic crisis, chain, whereas VK2 has an unsaturated side chain composed three with MDS (one RAEB, one RAEB in T and one CMML), of 4-13 isoprene units (polyprenylalcohol) (Figure 1 ). VK3 and three with post-MDS AML. Normal bone marrow cells lacks the side chain.
were obtained from a healthy volunteer. Several lines of evidence have shown that these congeners have some growth inhibitory effects on hepatoma cell lines such as Hep3B and Hep40, although the mechanisms of growth inhibition are not well understood. [1] [2] [3] In addition, gerCell surface antigen analysis anylgeraniol, a polyprenylalcohol composing the side chain of VK2, was previously reported to be a potent inducer of Flow cytometry was performed for cell surface antigen analyapoptosis in tumor cell lines. 4 sis. Cells were washed twice with PBS containing 5% FBS. In order to develop new therapy for leukemias, we examThen, 1 × 10 5 cells suspended in 0.5 ml of PBS containing 5% ined whether VK2 and its derivatives showed apoptosis-FBS and 0.02% NaN 3 which was raised against the 38 kDa mitochondrial mem- Therefore, for further studies, we used flow exposure to MK5, over 90% of the leukemia blasts showed the cytograms to monitor the cytocidal effect of these compounds typical microscopic features of apoptotic cells, ie they were on leukemia cells. shrunken and had fragmented nuclei (apoptotic bodies). blasts as assessed by microscopic examination of a bone marand case No. 11, whereas they were less effective in case No. row smear. Exposure to 10 M MKs for 48 h selectively elimin-12. In APL (cases No. 4 and No. 5), the MKs all showed a ated the leukemia cell population. GFO, but not FO or GGO, potent effect. In AML (M2), 10 M MKs showed a marked also induced selective elimination of leukemia cells, but its cytocidal effect on leukemia cells in case No. 2, whereas they effect was weaker than that of MKs. did not show a prominent effect in case No. 3. Regarding
In normal bone marrow mononucleated cells, CD33-posiPPAs, which have previously been reported to have a strong tive but not CD3-positive cells were eliminated to some extent apoptosis-inducing effect on various tumor cells, 4 GFO after 72 h of exposure to MK3, MK4, MK5 or GFO ( Figure 5 ). caused some apoptosis induction in case Nos 1, 2, 5, 6 and These data suggest that MKs have a specific cytocidal effect 11, but was less effective compared with the MKs in each on leukemia cells, but also have some cytotoxicity for normal case. GGO and FO (both 10 M) did not show any significant myeloid cells rather than their lymphoid counterparts. effects in the nine cases tested. Combination of MK5 and all-trans retinoic acid 100 nM ATRA with MK5, there was significant enhancement of the cytocidal-and apoptosis-inducing activities as compared enhances induction of apoptosis in acute promyelocytic leukemia with MK5 alone. Enhanced apoptosis was also demonstrated by increased cell surface expression of APO2.7, a 38 kDa mitochondrial membrane protein (7A6 antigen), that is known to All-trans retinoic acid (ATRA) is now well known to be highly effective for treating acute promyelocytic leukemia.
9-11 Since be expressed by cells undergoing apoptosis ( Figure 6 , lower panel). 7 Extension of the exposure time to 6 days led to more the MKs, particularly MK5, caused potent induction of apoptosis in APL cells (Figure 3 case Nos 4 and 5), we further prominent enhancement of both the cytocidal-and apoptosisinducing effects on NB4 cells of 10 nM ATRA plus MK5. As examined whether the combination of MK5 and ATRA enhanced the cytocidal effect on APL cells. First, we treated well as NB4 cells, the enhanced cytocidal effect of the combination of MKs and ATRA was reproduced when freshly isolated an APL-derived cell line, NB4; with either ATRA or MK5 alone or with the combination of MK5 plus ATRA, and then assessed APL cells from case No. 4 were tested. It was noteworthy that this enhancement was prominent and appeared to be more the cytocidal-and apoptosis-inducing effects. As shown in Figure 6 , 10-100 nM of ATRA alone showed no cytocidal effect than the additive effect obtained with a combination of 3 M MK5 plus 100 nM ATRA (Figure 7) . on NB4 cells during 3 days of culture. However, by combining 
Figure 5
Effect of menaquinones and polyprenylalcohols on normal marrow cells. Whole bone marrow mononucleated cells from a healthy volunteer were treated with 10 M of either MK or PPA for Figure 6 Combination of MKs and all-trans retinoic acid enhances 72 h. Then, the cells were stained with either FITC-conjugated antiinduction of apoptosis in NB4 cells. NB4 cells were incubated with CD33 or CD3 monoclonal antibody. Subsequently, the change of the either MK5 (10 M), ATRA (10 nM, 100 nM), or MK plus ATRA for 3-CD33-or CD3-positive cell distribution on the cytogram was exam-6 days. Apoptosis was examined by the ApopTag kit, the apoptotic ined, as shown in Figure 2b . In the present study, we demonstrated that VK2 and its ana- the apoptosis-inducing effect on APL cells (Figures 6 and 7) .
